Related Experiment Video
Updated: Jun 20, 2026
10:44
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
Published on: June 2, 2019
A new cytotoxic iridoid from Callicarpa nudiflora
Wen-Li Mei1, Zhuang Han, Hai-Bin Cui
1Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences, Haikou, 571101, Hainan, PR China.
Natural Product Research
|September 16, 2009
Summary
A novel iridoid, nudifloside, was isolated from Callicarpa nudiflora and demonstrated significant inhibitory effects against chronic myelogenous leukemia K562 cells. This finding offers potential for new leukemia treatments.
Area of Science:
- Phytochemistry and Natural Products Chemistry
- Pharmacology and Cancer Biology
Background:
- The exploration of natural products for therapeutic agents is crucial in drug discovery.
- Callicarpa species are known sources of bioactive compounds with diverse pharmacological activities.
Purpose of the Study:
- To isolate and characterize chemical constituents from the aerial parts of Callicarpa nudiflora.
- To evaluate the cytotoxic effects of isolated compounds on the chronic myelogenous leukemia K562 cell line.
Main Methods:
- Extraction of aerial parts of Callicarpa nudiflora using ethanol.
- Isolation and purification of compounds using chromatographic techniques.
- Structure elucidation through comprehensive physical and spectral data analysis (e.g., NMR, MS).
- In vitro cytotoxic activity assay using the K562 cell line.
Main Results:
- A new iridoid, nudifloside (1), was identified along with three known compounds.
- Nudifloside (1) exhibited potent inhibitory activity against K562 cells with an IC(50) value of 20.7 microg/mL.
- The known compound linearoside (2) also showed inhibitory effects, with an IC(50) value of 36.0 microg/mL.
Conclusions:
- Nudifloside is a novel bioactive iridoid with potential anti-leukemic properties.
- Callicarpa nudiflora is a promising source for the discovery of new anticancer agents.
- Further investigation into nudifloside's mechanism of action is warranted for therapeutic development.
